Latest News about Psychedelic/Assisted Therapies
Recent news which mentions Psychedelic/Assisted Therapies
Microdosing Unveiled: Expert's Take On The Practice's Ups & Downs
September 24, 2023
Tickers
META
From Benzinga
From Benzinga
Enveric Biosciences Nabs U.S. Patent For Novel Psilocybin Derivatives, Details Here
September 21, 2023
Tickers
ENVB
From Benzinga
From Benzinga
Congress To Discuss New Bill Banning Federal Intervention In States Where Psilocybin Is Legal
September 20, 2023
From Benzinga
Kentucky's $42M Ibogaine Budget Plan For Opioid Crisis Hears Testimonies At Second Meeting
September 19, 2023
From Benzinga
Psyched: MDMA Trials For PTSD, Congressional Amendments, Scotland's Consumption Site & More
September 18, 2023
From Benzinga
Hope For Postpartum Depression: This Company To Launch Clinical Trial On Next-Gen Psychedelic
September 18, 2023
Tickers
MSSTF
From Benzinga
Billionaire Steve Cohen Invests $19M In Cybin For Psychedelics R&D, Blake Mycoskie's $100M Pledge Update
September 18, 2023
From Benzinga
Psychedelics Researchers & Industry Leaders Weigh In On Groundbreaking PTSD Treatment News
September 15, 2023
Tickers
NUMIF
From Benzinga
Combining MDMA With Psilocybin Or LSD Could Reduce Difficult Trips, New Study Shows
September 13, 2023
Tickers
MNMD
From Benzinga
Swedish Foundation Supports Mental Health Innovation With New €3M Psychedelic Science Initiative
September 13, 2023
Tickers
CMPS
From Benzinga
Congress Update: House Committee Green Lights Psychedelics Amendments
September 13, 2023
From Benzinga
NY Consulting Firm Predicts Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years
September 12, 2023
From Benzinga
Michigan Resolution: Veterans Across US Should Have Access To Psychedelic-Assisted Therapy
September 08, 2023
From Benzinga
'Wolf Of Wall Street' Embraces Ibogaine For Addiction Recovery With Help Of 'Psychedelic Concierge'
September 08, 2023
From Benzinga
Optimi Health Will Supply Psychedelics To Canada's SAP, Secures CA$1M Private Financing
September 08, 2023
Tickers
OPTHF
From Benzinga
Shaping Federal Policy Around Psychedelic Therapy: APPA Teams Up With Daschle Group
September 07, 2023
From Benzinga
Psychedelics Reform Update: CA Bill's Final Vote, MA 2024 Legalization Ballot, HI Task Force, OR Funding And More
September 07, 2023
From Benzinga
Johns Hopkins Will Work With Clearmind On Alcohol Addiction Research Program
September 06, 2023
Tickers
CMND
From Benzinga
PharmaTher Aims To Mitigate Ketamine Shortage With New FDA Application
September 06, 2023
Tickers
PHRRF
From Benzinga
Compass Pathways Explores AI-Powered Predictive Model On Psilocybin Therapy For Depression
September 06, 2023
Tickers
CMPS
From Benzinga
Cybin's Intellectual Powerhouse Grows With New US Patent Covering Deuterated 5-MeO-DMT
September 05, 2023
From Benzinga
Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More
September 05, 2023
From Benzinga
Sacred Medicine Meets Wall Street: Legal Peyote Company Will Trade On Canadian Market
September 04, 2023
From Benzinga
Single Psilocybin Dose 'Significantly' Reduces Major Depression Symptoms, New Usona Phase 2 Trial Shows
September 03, 2023
From Benzinga
Pete Davidson Reveals He's Tried Ketamine To Cope With Depression
September 01, 2023
Tickers
JNJ
From Benzinga
UK Psychedelics Update: MPs Seek Rescheduling, Safe Consumption Sites, OD Prevention Fund
September 01, 2023
Tickers
UK
From Benzinga
Colorado's Psychedelic Future Unfolds: Regulators Host Community Meetings To Shape Industry Rules
August 31, 2023
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.